NasdaqCM:WORX

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

SCWorx Corp. provides software solutions for the management of health care providers’ foundational business applications in the United States. More Details


Snowflake Analysis

Imperfect balance sheet and overvalued.

Share Price & News

How has SCWorx's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: WORX's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0.7%

WORX

2.4%

US Healthcare Services

0.08%

US Market


1 Year Return

-53.8%

WORX

54.7%

US Healthcare Services

12.8%

US Market

Return vs Industry: WORX underperformed the US Healthcare Services industry which returned 54.7% over the past year.

Return vs Market: WORX underperformed the US Market which returned 12.8% over the past year.


Shareholder returns

WORXIndustryMarket
7 Day0.7%2.4%0.08%
30 Day-2.6%-2.4%-1.8%
90 Dayn/a10.2%7.2%
1 Year-53.8%-53.8%55.1%54.7%15.3%12.8%
3 Yearn/a103.1%101.8%39.2%29.9%
5 Yearn/a153.3%151.0%88.3%67.1%

Price Volatility Vs. Market

How volatile is SCWorx's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is SCWorx undervalued compared to its fair value and its price relative to the market?

2.3x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate WORX's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate WORX's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: WORX is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: WORX is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate WORX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: WORX is good value based on its PB Ratio (2.3x) compared to the US Healthcare Services industry average (5.1x).


Next Steps

Future Growth

How is SCWorx forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

37.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SCWorx has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has SCWorx performed over the past 5 years?

-62.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: WORX is currently unprofitable.

Growing Profit Margin: WORX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: WORX is unprofitable, and losses have increased over the past 5 years at a rate of 62.3% per year.

Accelerating Growth: Unable to compare WORX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WORX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).


Return on Equity

High ROE: WORX has a negative Return on Equity (-129.48%), as it is currently unprofitable.


Next Steps

Financial Health

How is SCWorx's financial position?


Financial Position Analysis

Short Term Liabilities: WORX's short term assets ($2.3M) do not cover its short term liabilities ($4.5M).

Long Term Liabilities: WORX's short term assets ($2.3M) exceed its long term liabilities ($294.0K).


Debt to Equity History and Analysis

Debt Level: WORX's debt to equity ratio (12.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if WORX's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: WORX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: WORX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 56.8% each year


Next Steps

Dividend

What is SCWorx current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate WORX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate WORX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if WORX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if WORX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of WORX's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.9yrs

Average board tenure


CEO

Marc Schessel (57 yo)

8.67yrs

Tenure

US$914,312

Compensation

Mr. Marc S. Schessel is Founder of SCWorx Corp. He serves as Chairman and Chief Executive Officer of SCWorx Corp since 2012 and its Treasurer and Secretary. He founded SCWorx’s predecessor (Primrose LLC) i ...


CEO Compensation Analysis

Compensation vs Market: Marc's total compensation ($USD914.31K) is above average for companies of similar size in the US market ($USD589.30K).

Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.


Board Members

NamePositionTenureCompensationOwnership
Marc Schessel
Founder8.67yrsUS$914.31k14.9%
$ 2.1m
Timothy Hannibal
President0.083yrUS$565.62k0.22%
$ 31.2k
Mark Shefts
Independent Director0.33yrno data0.55%
$ 78.7k
Charles Miller
Independent Director1.92yrsUS$203.11k0.035%
$ 4.9k
Steven Wallitt
Independent Director0.92yrno data0.54%
$ 77.1k

0.9yrs

Average Tenure

58yo

Average Age

Experienced Board: WORX's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 44.1%.


Top Shareholders

Company Information

SCWorx Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SCWorx Corp.
  • Ticker: WORX
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$14.236m
  • Shares outstanding: 9.49m
  • Website: https://www.scworx.com

Number of Employees


Location

  • SCWorx Corp.
  • 590 Madison Avenue
  • 21st Floor
  • New York
  • New York
  • 10022
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
WORXNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDFeb 2019
4R8DB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2019
4R8BST (Boerse-Stuttgart)YesCommon SharesDEEURFeb 2019

Biography

SCWorx Corp. provides software solutions for the management of health care providers’ foundational business applications in the United States. The company provides services related to repair, normalization ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/21 06:53
End of Day Share Price2020/09/18 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.